Literature DB >> 3017404

Eccrine spiradenoma of eyelid: case report.

B K Ahluwalia, A K Khurana, A D Chugh, V G Mehtani.   

Abstract

A case report is presented of eccrine spiradenoma, a benign sweat gland tumour which, though not uncommon generally, is rare in the eyelid. The possibility of sweat gland tumour should be kept in mind in the diagnosis of eyelid tumours.

Entities:  

Mesh:

Year:  1986        PMID: 3017404      PMCID: PMC1040775          DOI: 10.1136/bjo.70.8.580

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  CLEAR CELL HIDRADENOMA OR MYOEPITHELIOMA OF THE EYELID.

Authors:  M BONIUK; B HALPERT
Journal:  Arch Ophthalmol       Date:  1964-07

2.  A method for partial and total upper lid reconstruction.

Authors:  N L CUTLER; C BEARD
Journal:  Am J Ophthalmol       Date:  1955-01       Impact factor: 5.258

3.  Eccrine spiradenoma.

Authors:  D W KERSTING; E B HELWIG
Journal:  AMA Arch Derm       Date:  1956-03

4.  A light- and electron-microscopic study of a case of multiple eccrine spiradenoma.

Authors:  B L MUNGER; B M BERGHORN; E B HELWIG
Journal:  J Invest Dermatol       Date:  1962-05       Impact factor: 8.551

5.  Porosyringoma. Report of a case.

Authors:  L S Tulman; M K Jack
Journal:  Am J Ophthalmol       Date:  1965-12       Impact factor: 5.258

  5 in total
  3 in total

1.  Malignant nodular hidradenoma of the eyelid: a rare sweat gland tumor.

Authors:  Abdulla Al Baghli; Suresh S Reddy; Maragaret A Reddy
Journal:  Middle East Afr J Ophthalmol       Date:  2010-10

Review 2.  Current management approach to hidradenocarcinoma: a comprehensive review of the literature.

Authors:  Abhishek Soni; Nupur Bansal; Vivek Kaushal; Ashok Kr Chauhan
Journal:  Ecancermedicalscience       Date:  2015-03-19

3.  Case of recurrence of spiradenoma in palpebral conjunctiva.

Authors:  Shinya Oie; Akira Sawada; Kiyofumi Mochizuki; Kozue Tsuji; Yoshinobu Hirose; Chiemi Saigo; Hiroshi Yoshikawa
Journal:  BMC Ophthalmol       Date:  2014-06-27       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.